US regulator orders new eye risk warnings for Ozempic and Wegovy

Health regulator wants labels to include warning on GLP-1 drugs of potential increased risk of vision loss

US regulator orders new eye risk warnings for Ozempic and Wegovy
Health regulator wants labels to include warning on GLP-1 drugs of potential increased risk of vision loss